Hemoglobinopathies

References

1. 1.↵
   1. Warghade S,
   2. Britto J,
   3. Haryan R,
   4. Dalvi T,
   5. Bendre R,
   6. Chheda P, et al.

   Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of india: A report of 65779 cases. J Lab Physicians 2018; 10: 73–79.

   OpenUrl
2. 2.↵
   1. Weatherall DJ,
   2. Clegg JB.

   Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ 2001; 79: 704–712.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Somervaille T.

   Disorders of hemoglobin: Genetics, pathophysiology, and clinical management. J R Soc Med 2001; 94: 602–603.

   OpenUrl
4. 4.↵
   1. Memish ZA,
   2. Saeedi MY.

   Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and ß-thalassemia in Saudi Arabia. Ann Saudi Med 2011; 31: 229–235.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Alsaeed ES,
   2. Farhat GN,
   3. Assiri AM,
   4. Memish Z,
   5. Ahmed EM,
   6. Saeedi MY, et al.

   Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011-2015. Journal of Epidemiology and Global Health 2018; 7: S41–S47.

   OpenUrl
6. 6.↵
   1. Zaini RG.

   Sickle-cell anemia and consanguinity among the Saudi Arabian population. Archives of Medicine 2016; 8: 1–3.

   OpenUrl
7. 7.↵
   1. Abu-Shaheen A,
   2. Heena H,
   3. Nofal A,
   4. Abdelmoety DA,
   5. Almatary A,
   6. Alsheef M, et al.

   Epidemiology of thalassemia in gulf cooperation council countries: A systematic review. Biomed Res Int 2020; 2020: 1509501.

   OpenUrl
8. 8.↵
   1. Herbert L.
   2. Muncie J,
   3. Campbell JS.

   Alpha and beta thalassemia. AFP 2009; 80: 339–344.

   OpenUrl
9. 9.↵
   1. Origa R.

   ß-thalassemia. Genet Med 2017; 19: 609–619.

   OpenUrl
10. 10.↵
    1. Chonat S,
    2. Quinn CT.

    Current standards of care and long term outcomes for thalassemia and sickle cell disease. Adv Exp Med Biol 2017; 1013: 59–87.

    OpenUrl
11. 11.↵
    1. Ashley-Koch A,
    2. Yang Q and
    3. Olney RS.

    Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol 2000; 151: 839–845.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Xu JZ,
    2. Thein SL.

    The carrier state for sickle cell disease is not completely harmless. Haematologica 2019; 104: 1106–1111.

    OpenUrlFREE Full Text
13. 13.↵
    1. Kato GJ,
    2. Piel FB,
    3. Reid CD,
    4. Gaston MH,
    5. Ohene-Frempong K,
    6. Krishnamurti L, et al.

    Sickle cell disease. Nat Rev Dis Primers 2018; 4: 18010.

    OpenUrl
14. 14.↵
    1. Lobitz S,
    2. Telfer P,
    3. Cela E,
    4. Allaf B,
    5. Angastiniotis M,
    6. Backman Johansson C, et al.

    Newborn screening for sickle cell disease in europe: Recommendations from a pan-european consensus conference. Br J Haematol 2018; 183: 648–660.
15. 15.↵
    1. Bravo-Urquiola M,
    2. Arends A,
    3. Montilla S,
    4. Velásquez D,
    5. Garcìa G,
    6. Alvarez M, et al.

    [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela]. Invest Clin 2004; 45: 309–315. Spanish.

    OpenUrlPubMed
16. 16.↵
    1. Mir SA,
    2. Alshehri BM,
    3. Alaidarous M,
    4. Banawas SS

    , Dukhyil, Abdul Aziz A. Bin and Alturki MK. Prevalence of hemoglobinopathies (ß-thalassemia and sickle cell trait) in the adult population of al majma’ah, Saudi Arabia. Hemoglobin 2020; 44: 47–50.

    OpenUrl
17. 17.↵
    1. Chakravorty S,
    2. Dick MC.

    Antenatal screening for haemoglobinopathies: Current status, barriers and ethics. Br J Haematol 2019; 187: 431–440.

    OpenUrl
18. 18.↵
    1. Saffi M,
    2. Howard N.

    Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for ß-thalassaemia in the middle east: A scoping review. Public Health Genomics 2015; 18: 193–203.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Williams TN,
    2. Weatherall DJ.

    World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2012; 2: a011692.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Mir SA,
    2. Alshehri BM,
    3. Alaidarous M,
    4. Banawas SS

    , Dukhyil, Abdul Aziz A. Bin and Alturki MK. Prevalence of hemoglobinopathies (ß-thalassemia and sickle cell trait) in the adult population of al majma’ah, Saudi Arabia. Hemoglobin 2020; 44: 47–50.

    OpenUrl
21. 21.↵
    1. Dahlawi HA,
    2. Zaini RG,
    3. Zamzami OM,
    4. Alhumyani AF.

    Hemoglobinopathies among Saudi adults at Taif city, Saudi Arabia. Russian Journal of Hematology and Transfusiology 2018; 63: 159–165.

    OpenUrl